Conditions: Chronic Kidney Diseases; Inflammation
Intervention: Biological: Ziltivekimab
Sponsor: Corvidia Therapeutics
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition
May 21, 2019ClinicalTrials.govComments OffNephrologyAdvanced | Antibody | Chronic | Disease | Evaluate | Inflammation | Inhibition | Mediated | Patients | Reduction | Renal | Trial | Utilizing
Comments
